"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."
Sir John Bell
Articles tagged with: Deloitte
Three New Trustees Appointed
15th May 2014
Birmingham-based blood cancer charity Cure Leukaemia has announced a record-breaking 42% increase in their annual fundraising for the year ended October 31st 2013. The charity raised £863,474 last year, a figure that is worth over £8 million in potentially life saving...
Deloitte's Charity Luncheon raises nearly £5,000
10th March 2014
To coincide with International Women’s Day, Deloitte Birmingham staged a charity luncheon to support the work of Cure Leukaemia across the region. TV personality and successful businesswoman, Llewela Bailey had the audience in numerous bouts of laughter as she spoke over lunch, recalling...
Charity Partners visit Leukaemia Centre
29th January 2014
Last week staff from a number of Cure Leukaemia’s charity partners took time out from their normal working Friday to visit the Centre for Clinical Haematology at the Queen Elizabeth Hospital. The group included Sheila Newbury the Regional Corporate Responsibility Manager at Deloitte...
Deloitte backs Cure Leukaemia in 10th anniversary year
13th September 2013
Cure Leukaemia, has been selected as the charity partner for Deloitte in Birmingham in 2013/14. The leading business advisory firm, which employs over 600 people at its Birmingham office, is backing Cure Leukaemia’s vision to raise £10 million over the next 10 years. Deloitte joins a roster...
PREV
1
NEXT